What is the survival rate for lymphoma?
We have now discovered through clinical investigation and research that the prognosis of Hodgkin lymphoma is closely related to the type and stage of the tissue. If it is lymphocyte-dominant type, the prognosis is better. Generally speaking, the five-year survival rate is It can reach more than 94%. If it is a stage of Hodgkin lymphoma, then it is stage one, and the five-year survival rate is 92.5%.
For stage II, the five-year survival rate can reach 86.3%. For stage III Hodgkin lymphoma, the five-year survival rate can reach 69.5%. For stage IV Hodgkin lymphoma, the survival rate is 5 In years, it is 31.9%. So if there are systemic symptoms, then his survival rate will be worse than without systemic symptoms.
Generally speaking, the prognosis of children and the elderly is worse than that of young and middle-aged people. The prognosis of women is often better than that of men. This is Hodgkin lymphoma. Then non-Hodgkin lymphoma is different. The prognosis of non-Hodgkin lymphoma is also closely related to the pathological type and clinical stage.
Generally speaking, if it is diffuse lymphocyte differentiation, the 6-year survival rate is 61%. If it is diffuse lymphocyte differentiation, the 6-year survival rate is 42%. If it is lymphoblastoma, the 6-year survival rate is 42%. For cellular lymphoma, the 4-year survival rate is only 30%. For low-grade lymphoma, if it can be detected early and treated appropriately, it can have a survival period of 5 to 10 years or even longer.
Some highly malignant lymphomas are sensitive to chemotherapy and radiotherapy. If they receive reasonable treatment, their survival time can be significantly prolonged. Therefore, through our clinical investigation, we found that the survival time of patients with Hodgkin lymphoma is generally longer than that of non-Hodgkin lymphoma patients. Patients with gold lymphoma live longer.